IGF1 treatment was reported to partially alleviate RTS-like symptoms in Mecp2-deficient mice [56] and resulted in increased numbers of glutamatergic synapses on RTS patient-derived neurons, too [53]. This evidence concerns the gene MECP2 and Rett syndrome.